MIT-001, a Mitochondria-Targeted ROS Scavenger, Ameliorates DSS-Induced Colitis and Is Associated with Reduced HMGB1 and IL-1β Expression
International Journal of Molecular Sciences · 06.07.2026 · 27 (13) · 6051
DOI: 10.3390/ijms27136051 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.07.2026. Verfasst von Dongwoo Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: HMGB1 Protein, Colitis, Interleukin-1beta, Mitochondria. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea University.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation in which excessive cell death and the release of damage-associated molecular patterns (DAMPs) such as high-mobility group box 1 (HMGB1) amplify mucosal injury. Although necrosis—particularly regulated forms including necroptosis and ferroptosis—has emerged as a contributor to IBD pathogenesis, the therapeutic potential of targeting necrotic cell death remains incompletely explored. We investigated whether MIT-001 (previously known as NecroX-7), a mitochondria-targeted reactive oxygen species (ROS) scavenger with anti-necrotic activity, ameliorates intestinal inflammation in an acute dextran sulfate sodium (DSS)-induced colitis model. In vitro, MIT-001 reduced hydrogen peroxide-induced necrotic cell death in IEC-18 intestinal epithelial cells and was associated with a qualitative reduction in the 55-kDa cleaved poly(ADP-ribose) polymerase-1 (PARP-1) fragment (a marker of necrosis), with no apparent change in the apoptosis-related 89-kDa fragment. In vivo, oral administration of MIT-001 to C57BL/6 mice with DSS-induced colitis was associated with preservation of colon length, reduced histological injury, and a marked decrease in HMGB1-positive cells in colonic tissue. Among pro-inflammatory cytokines, IL-1β expression was significantly reduced, while IL-12, monocyte chemoattractant protein-1 (MCP-1), and TNF-α showed non-significant downward trends. These findings indicate that MIT-001 ameliorates DSS-induced colitis in association with reduced HMGB1 and IL-1β expression, supporting further investigation of mitochondria-targeted anti-necrotic strategies as a potential adjunctive approach in IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan 15355, Republic of Korea.
- Mitoimmune Therapeutics Inc., Seoul 05836, Republic of Korea.
ORCID-Profile: Dongwoo Kim, Jung Wan Choe, Seung Young Kim, Jong Jin Hyun, Young Kul Jung, Hyung Joon Yim, Ja Seol Koo
Förderung
- National Research Foundation of Korea
- Korea University
Zitieren
APA
Kim, D., Kim, S. H., Choe, J. W., Kim, S. Y., Hyun, J. J., Jung, S. W., Jung, Y. K., Yim, H. J., & Koo, J. S. (2026). MIT-001, a Mitochondria-Targeted ROS Scavenger, Ameliorates DSS-Induced Colitis and Is Associated with Reduced HMGB1 and IL-1β Expression. International Journal of Molecular Sciences, 27(13), 6051. https://doi.org/10.3390/ijms27136051
Vancouver
Kim D, Kim SH, Choe JW, Kim SY, Hyun JJ, Jung SW, et al. MIT-001, a Mitochondria-Targeted ROS Scavenger, Ameliorates DSS-Induced Colitis and Is Associated with Reduced HMGB1 and IL-1β Expression. International Journal of Molecular Sciences. 2026;27(13):6051. doi:10.3390/ijms27136051
BibTeX
@article{Kim2026,
author = {Kim, Dongwoo and Kim, Soon Ha and Choe, Jung Wan and Kim, Seung Young and Hyun, Jong Jin and Jung, Sung Woo and Jung, Young Kul and Yim, Hyung Joon and Koo, Ja Seol},
title = {MIT-001, a Mitochondria-Targeted ROS Scavenger, Ameliorates DSS-Induced Colitis and Is Associated with Reduced HMGB1 and IL-1β Expression},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {6051},
doi = {10.3390/ijms27136051}
}
EUVIMED